通过在骨质母细胞中激活PI3K/AKT/mTOR通路,抑制GCNT2促进了骨质母细胞的分化
Yansheng Huang1, Sibo Wang1, Dong Hu2
1Department of Spine Surgery, Honghui Hospital, Xi'an Jiaotong University, Xi'an, 710000, Shaanxi, China.
Scientific reports
|November 26, 2025
概括
葡萄糖胺基 (N-乙) 转移酶2 (GCNT2) 基因倒置通过激活PI3K/AKT/mTOR通路,促进骨质疏松症中的骨质细胞分化. 这表明GCNT2抑制是骨质疏松症治疗的潜在治疗策略.
科学领域:
- 骨生物学和新陈代谢
- 分子内分泌学分子内分泌学
- 生物化学 生化学
背景情况:
- 骨质疏松症 (OP) 是一种复杂的骨代谢疾病,具有具有挑战性的病变发生.
- 了解OP的调节机制需要进一步研究基因表达.
- 微阵列分析确定了GCNT2作为OP中潜在的重要基因.
研究的目的:
- 为了研究葡萄糖胺基 (N-乙) 转移酶2 (GCNT2) 在骨质疏松症中的作用.
- 探索在OP中准GCNT2的治疗潜力.
- 阐明涉及GCNT2-介导骨质细胞分化中的分子途径.
主要方法:
- 利用微阵列分析来识别OP患者中差异表达的基因.
- 采用MC3T3-E1骨质母细胞作为OP的体外模型,由甲 (Dex) 诱导.
- 通过qRT-PCR和西部斑分析评估骨质细胞分化标志物 (ALP,ARS,Runx2,OCN,OPN).
主要成果:
- 在OP患者和用Dex治疗的骨质母细胞中发现GCNT2的升高调节.
- 抑制GCNT2增强了骨质母细胞分化标志物,并与PI3K/AKT/mTOR途径有关.
- 用LY294002抑制PI3K减弱了GCNT2淘汰的作用,证实了途径的参与.
结论:
- 在OP模型中,GCNT2上调会损害骨质母细胞分化.
- 抑制GCNT2通过激活PI3K/AKT/mTOR信号通路来促进骨质母细胞分化.
- GCNT2倒置显示为潜在的骨质疏松症治疗策略的前景,需要进一步进行临床前评估.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
5.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.2K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
TGF - β Signaling Pathway
10.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K
Osteoclasts in Bone Remodeling
3.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.8K
Canonical Wnt Signaling Pathway
10.3K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.3K
Calmodulin-dependent Signaling
5.9K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.9K


